Composition and methods for extracting mycotoxins

Abstract

Disclosed is a composition for extracting mycotoxins or aflatoxins from a food sample. The methods using the composition to detect and analyze the aflatoxins are also provided.

Claims

1. A liquid concentrate effective for extracting mycotoxins in a sample, comprising: an effective amount of one or more of surfactants selected from the group consisting of sodium dodecyl sulfate (SDS) and polysorbate 20; and an effective amount of buffering salts consisting of sodium chloride and disodium phosphate (Na.sub.2HPO.sub.4); wherein the effective amount of the one or more surfactants ranges from about 2.4 to 7.2 wt % and the effective amount of each of the buffering salts ranges from about 6 to 18 wt %, or wherein the effective amount of the one or more surfactants ranges from about 5 to 15% by volume and the effective amount of each of the buffering salts ranges from about 6 to 18 wt %.

2. The liquid concentrate of claim 1, wherein the one or more surfactants comprise about 2.4 to 7.2 wt % sodium dodecyl sulfate (SDS).

3. The liquid concentrate of claim 1, wherein the one or more surfactants are included from about 2.4 to 7.2 wt %.

4. The liquid concentrate of claim 1, wherein the one or more surfactants comprise sodium dodecyl sulfate (SDS).

5. The liquid concentrate of claim 1, comprising about 6 wt % sodium dodecyl sulfate (SDS), about 7 wt % sodium chloride (NaCl), and about 7 wt % disodium phosphate (Na.sub.2HPO.sub.4).

6. The liquid concentrate of claim 1, wherein the one or more surfactants are included from about 5 to 15% by volume.

7. The liquid concentrate of claim 6, wherein the one or more surfactants comprise polysorbate 20.

8. The liquid concentrate of claim 6, comprising polysorbate 20 at about 10 volume %, sodium chloride at about 12.4 wt %, and disodium phosphate at about 2.8 wt %.

Description

BRIEF DESCRIPTION OF DRAWING

(1) FIG. 1 illustrates an exemplary process of extracting and detecting aflatoxins according to an exemplary embodiment using a composition of the present invention.

(2) FIG. 2 illustrates an exemplary process of extracting and detecting aflatoxins according to an exemplary embodiment using a first and second concentrated liquid of the present invention.

(3) FIG. 3 illustrates another exemplary process of extracting and detecting aflatoxins according to an exemplary embodiment using a first and second concentrated liquid of the present invention.

DETAILED DESCRIPTION OF THE INVENTION

(4) The present invention provides a composition and a method which can be used for extracting and detecting mycotoxins from a sample without using hazardous organic solvents. Particularly, the composition of the invention may be optimized for the extractions of such mycotoxins in aqueous solution.

(5) It is to be understood that this invention is not limited to particular methods and experimental conditions described, as such methods and conditions may vary. It is also to be understood that the terminology used herein is for the purpose of describing particular embodiments only, and is not intended to be limiting, since the scope of the present invention will be limited only by the appended claims.

(6) Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. As used herein, the term about, when used in reference to a particular recited numerical value or range of values, means that the value may vary from the recited value by no more than 1%. For example, as used herein, the expression about 100 includes 99 and 101 and all values in between (e.g., 99.1, 99.2, 99.3, 99.4, etc.).

(7) Although any methods and materials similar or equivalent to those described herein can be used in the practice or testing of the present invention, the preferred methods and materials are now described. All publications mentioned herein are incorporated herein by reference in their entirety.

Definition

(8) The term mycotoxin, as used herein, is a toxic secondary metabolite produced by organisms of the fungi kingdom, commonly known as molds. The term mycotoxin is usually applied to the toxic chemical products produced by fungi that readily colonize crops. One mold species may produce many different mycotoxins, and the same mycotoxin may be produced by several species

(9) The term aflatoxin, as used herein, is a type of mycotoxin, which is produced by Aspergillus flavus and Aspergillus parasiticus. A variety of aflatoxins have been identified as aflatoxin types B.sub.1, B.sub.2, G.sub.1, G.sub.2, M.sub.1 and M.sub.2

Aflatoxin B.SUB.1

(10) Aflatoxins occur naturally in peanuts, peanut meal, cottonseed meal, corn, dried chili peppers, and the like. Aflatoxins are a frequent contaminant of the human food supply in many areas of the world and are statistically associated with increased incidence of human liver cancer in Asia and Africa, in particular.

(11) The term sample, as used herein, refers to any mixtures of molecules that comprise at least one molecule that is subjected to extraction, detection, separation, analysis or profiling. Particular examples in the present invention include, but are not limited to, food samples such as produce or environmental samples. Particularly, the food samples may be produce or crops such as corn, peanuts, cotton or cottonseed, wheat, soybeans, rice, and the like. In certain exemplary embodiments, the samples may include a detectable range of mycotoxins such as aflatoxins.

(12) As used herein, the term surfactant refers to a chemical compound which reduces a surface tension between two liquids or between a liquid and a solid. Surfactants may act as detergents, wetting agents, emulsifiers, foaming agents, dispersants and the like. In certain embodiments, the surfactants may be used to stabilize hydrophobic organic molecules, such as lipid, oil, aromatic compounds, hydrophobic proteins and the like, in an aqueous solution.

(13) As used herein, the term polymer refers to a high molecular-weight molecule which contains repeating subunits and imparts specific properties to a solution. In certain embodiments of the present invention, the polymer may have a hydrophilic group, hydrophobic group or combined groups, and further may be used as a surfactant or a surface modifier.

(14) As used herein, the term viscosity modifier refers to an ingredient in a solution to modulate the viscosity of the solution. The viscosity modifier may be particularly added to provide higher viscosity, surface tension or flowability. In addition, the viscosity modifier may have mild chemical activity in the solution. In certain embodiments, in aqueous solution, exemplary viscosity modifiers may be glucose, sucrose or cellulose, such that the viscosity or density of the solution may increase.

(15) As used herein, the buffering salt refers to any types of salts which can be dissolved in water or aqueous solution and maintain buffering condition of the solution. The buffering salt generally includes salts, acidic salts, basic salts or combinations thereof. The buffering salt may not react with other components in the solution but influence on pH, buffering or electrolytic properties thereof.

(16) The terms analysis or analyzing are used interchangeably and refer to any of the various methods of separating, detecting, isolating, purifying, solubilizing, detecting and/or characterizing small nutrient molecules (e.g., vitamins). Examples include, but are not limited to, solid phase extraction, solid phase micro extraction, electrophoresis, mass spectrometry, e.g., MALDI-MS or ESI, liquid chromatography, e.g., high performance, e.g., reverse phase, normal phase, or size exclusion, ion-pair liquid chromatography, liquid-liquid extraction, e.g., accelerated fluid extraction, supercritical fluid extraction, microwave-assisted extraction, membrane extraction, soxhlet extraction, precipitation, clarification, electrochemical detection, staining, elemental analysis, Edmund degradation, nuclear magnetic resonance, infrared analysis, flow injection analysis, capillary electrochromatography, ultraviolet detection, and combinations thereof.

(17) The term affinity chromatography, as used herein, refers to a method of separating chemical or biochemical species in a sample based on a highly specific interaction between substrate and the ligand. Particular examples of such specificity may be between antigen and antibody, between enzyme and substrate, or between receptor and ligand. In affinity chromatography, capturing molecules having specificity to analytes can be immobilized in the chromatographic material or resin in a column or diagnostic tool and the analytes of interest can be seized by the resin. In certain exemplary embodiments, aflatoxins can be recognized and captured by their specific antibodies immobilized in an affinity chromatography column or colloidal particles.

(18) The term test strip, as used herein, refers to a diagnostic strip or dipstick used for determining presence of analytes. Chemical or biochemical species which have specificity to analytes may be immobilized on colloidal particles and the analytes specifically bound to the particles on the strip may be detected and analyzed quantitatively or qualitatively. In certain exemplary embodiments, a test strip may include aflatoxin-specific antibodies for detecting aflatoxins in a sample.

(19) Extraction of Mycotoxins

(20) The present invention provides a novel extraction of mycotoxins without using organic solvents, and also discloses a composition which can be used for the extraction in aqueous solution.

(21) In one aspect, disclosed is extraction of mycotoxins from a sample in aqueous solutions, whereby the use of organic solvent may be avoided. Accordingly, the composition and concentrated liquids of the invention may be used for efficiently extracting mycotoxins having high hydrophobicity. In particular, the composition may include surfactants or dispersants to solubilize or stabilize organic molecules in aqueous solution. In an exemplary embodiment, the composition may include one or more of surfactants, one or more of polymers, one or more of viscosity modifiers, one or more of buffering salts and the like.

(22) Extracting, as used herein, is a chemical process to transfer chemical species from one phase to another phase, such as from organic solvent phase to aqueous phase. In certain exemplary embodiments, the mycotoxins in sample such as solid or oil phase can be transferred to aqueous liquid phase, such that detection can be performed. In an exemplary embodiment, aflatoxins may be transferred from the food sample and dissolved in water by use of the composition in the invention.

(23) In certain embodiments, the extracting may be performed by generally known methods in the art. Exemplary extracting processes may be, but are not limited to, shaking, vortexing, ultrasonication, heat reflux, microwave-assisted extraction, controlled pressure drop extraction, and the like.

(24) In certain exemplary embodiments, the mycotoxins to be extracted may be, but are not limited to, aflatoxin, fumonisin, ochratoxin, zearalenone and the like. Among those mycotoxins, aflatoxins may be effectively extracted and analyzed using the composition of the invention.

(25) In certain exemplary embodiments, the sample may be a food or beverage sample, environmental sample, or biological sample, without limitation. The food sample may include produce, food products, and the like. Exemplary food samples may be, but not limited to, corn, maize, peanuts, cotton or cottonseed, wheat, soybeans, rice, dairy products, breakfast cereals, baby food, canned fruits, and related commodity food products. When the sample is provided as solid, the sample may be prepared appropriately and combined with the composition of the invention and water. When the sample is provided as aqueous liquid, the sample may be directly combined with the composition of the invention in a predetermined range thereof.

(26) Composition

(27) The present invention provides a composition or concentrated liquids for extracting mycotoxins included in a food sample. The composition or concentrated liquids particularly can be used for the method of extracting mycotoxins without using an organic solvent. According to various exemplary methods as described above, the composition may be combined with the sample including mycotoxins and water before analyzing the sample.

(28) In one aspect, provided is the composition including: one or more of surfactants, one or more of polymers, one or more of viscosity modifiers, and one or more of buffering salts.

(29) In another aspect, provided are concentrated liquids including one or more of surfactants, and one or more of buffering salts. In particular embodiments when concentrated liquids are used, the concentrated liquids do not contain polymers or viscosity modifiers

(30) Surfactant, as disclosed above, is used to modify the surface of analytes and consequently stabilizes the analytes. In certain embodiments, surfactant in the solution may include a hydrophilic group, a hydrophobic group or a combination thereof and accordingly, stabilize the analytes in aqueous environments. In certain exemplary embodiments, the surfactant may solubilize and stabilize aflatoxins which possess series of aromatic rings in their structure in water without any organic solvent. Accordingly, the dispersion or extraction of aflatoxins may be substantially improved by addition of surfactants.

(31) In certain embodiments, the surfactants used in the invention may include a generally used chemical surfactant in the art. For example, polysorbate 20, sodium stearate, 4-(5-dodecyl) benzenesulfonate, sodium dodecyl sulfate (SDS), trimethylhexadecyl ammonium chloride and the like may be used in the present invention, but the examples may not be limited thereto.

(32) In certain exemplary embodiments of the composition of the invention, the surfactant may be included in an amount of about 2 to 10 wt %, of about 3 to 9 wt %, of about 4 to 8 wt %, of about 5 to 7 wt %, of about 5.5 to 7.5 wt %, or particularly of about 6 wt %. In certain exemplary embodiments, the composition may include SDS as surfactant component.

(33) In an exemplary embodiment, the composition may include SDS in an amount of about 6 wt %, based on the total weight of the composition.

(34) In certain embodiments when the concentrated liquids of the invention are used, the first and second concentrated liquids include different surfactants. In certain other embodiments, the concentrated liquids use the same surfactants, optionally in addition to other surfactants. In certain exemplary embodiments, the first concentrated liquid includes a first surfactant which may be included in an amount of about 2.4 to 7.2 wt %, or particularly of about 4.8 wt %. In certain exemplary embodiments the second concentrated liquid includes a second surfactant which may be included in an amount of about 5 to 15% by volume. In certain exemplary embodiments, the concentrated liquids include SDS and polysorbate 20 as surfactant components.

(35) In an exemplary embodiment, the first concentrated liquid includes SDS in an amount of about 4.8 wt %, based on the total weight of the concentrated liquid.

(36) In an exemplary embodiment, the second concentrated liquid includes polysorbate 20 in an amount of about 10% by volume, based on the total volume of the concentrated liquid.

(37) Polymer, as used herein, may be a water-soluble polymer and also be used as surfactant or surface modifier, which may modify the surface of analytes. In addition, the polymer may stabilize a buffering condition, such as pH or salt concentration.

(38) In certain embodiments, the polymer is, but not limited to, polyacrylic acid, polyol, polyethylene glycol (PEG), or polyvinylpyrrolidone. In an exemplary embodiment, the composition may include polyethylene glycol (PEG). The PEG having an average molecular weight in a range of about 1,000 to about 40,000 may be included in the composition, or particularly, the PEG having an average molecular weight of about 6,000; 8,000; 10,000; 12,000; 14,000; 16,000; 18,000; 20,000; 22,000; 24,000; 26,000; 28,000; 30,000, 32,000 may be used. In certain exemplary embodiments, PEG having an average molecular weight of about 20,000 may be used.

(39) In certain embodiments, the polymer may be included in an amount of about 30 to 50 wt %, of about 32.5 to 47.5 wt %, of about 35 to 45 wt %, of about 37.5 to 42.5 wt % or particularly of about 40 wt %, based on the total weight of the composition.

(40) In an exemplary embodiment, the PEG 20,000 may be included in an amount of about 40 wt % in the composition, based on the total weight of the composition.

(41) Viscosity modifier, as used herein, may stabilize an extracting solution when the composition of the invention is dissolved in water and stabilize the viscosity of the extracting solution in various temperature or pressure range. In certain embodiments, the viscosity modifier in the invention may be, but not limited to, a water-soluble organic polymer, cellulose, sucrose, glucose, or mannitol.

(42) In certain embodiments, the viscosity modifier may be included in an amount of about 30 to 50 wt %, of about 32.5 to 47.5 wt %, of about 35 to 45 wt %, of about 37.5 to 42.5 wt % or particularly of about 40 wt %, based on the total weight of the composition.

(43) In an exemplary embodiment, sucrose may be included in an amount of about 40 wt % in the composition, based on the total weight of the composition.

(44) Buffering salt may be included in the composition to maintain buffering condition, salt concentration and pH of an extracting solution. In certain exemplary embodiments, the buffering salt may be a salt, an acidic salt, a basic salt or combinations thereof. In yet certain exemplary embodiments, the buffering salt may include, but is not limited to, sulfate, citrate, acetate, chloride, bromide, iodide, nitrate, bisulfate, phosphate, lactate, salicylate, acid citrate, tartrate, oleate, tannate, pantothenate, bitartrate, ascorbate, succinate, maleate, besylate, fumarate, gluconate, glucuronate, saccharate, formate, benzoate, glutamate, methanesulfonate, ethanesulfonate, benzenesulfonate, and p-toluenesulfonate salts and the like. Exemplary salts may be, but are not limited to, sodium chloride, sodium sulfate, sodium citrate, sodium acetate, sodium bromide, and sodium iodide, potassium chloride, potassium acetate, potassium bromide, potassium iodide and the like. Exemplary acidic salts may include, but are not limited to, sodium bicarbonate (NaHCO.sub.3), sodium hydrosulfide (NaHS), sodium bisulfate (NaHSO.sub.4), monosodium phosphate (NaH.sub.2PO.sub.4), disodium phosphate (Na.sub.2HPO.sub.4) and the like. Exemplary basic salts may be, but are not limited to, calcium carbonate, sodium carbonate, potassium cyanide, and the like.

(45) In certain exemplary embodiments when the composition of the invention is used, the salt and/or acidic salt may be included, each respectively, in an amount of about 5 to 9 wt %, of about 6 to 8 wt %, of about 6.5 to 7.5 wt % or particularly of about 7 wt %. Alternatively, the total amount of salt and acidic salt in the compound may be in an amount of about 10 to 18 wt %, of about 11 to 17 wt %, of about 12 to 16 wt %, or of about 13 to 15 wt %. In an exemplary embodiment, sodium chloride (NaCl) and sodium dihydrogen phosphate (NaH.sub.2PO.sub.4) may be used in an amount of about 7 wt % respectively.

(46) In certain exemplary embodiments when the concentrated liquids of the invention are used, the salt and/or acidic salt may be included, each respectively, in an amount of about 6 to 18 wt %, or particularly of about 12.4 wt %. Alternatively, the total amount of salt and acidic salt in the compound may be in an amount of about 1.4 to 4.2 wt %, In an exemplary embodiment, sodium chloride (NaCl) and sodium monohydrogen phosphate (NaH.sub.2PO.sub.4) may be used in an amount of about 12.4 wt % and 2.8 wt % respectively.

(47) In certain exemplary embodiments, the pH of the extracting solution which is formed by combining the composition and water may be maintained by the salt and acidic salt in a range of about 4 to 9, of about 5 to 9, or particularly about 6-8 by addition of salt and acidic salt compounds.

(48) According to an exemplary embodiment, the composition may include: poly ethylene glycol (PEG), sucrose, sodium chloride, sodium dihydrogen sulfate, and sodium dodecyl sulfate (SDS). Particularly, the composition may include: PEG in an amount of about 40 wt %, sucrose in an amount of about 40 wt %, NaCl in an amount of about 7 wt %, NaH.sub.2PO.sub.4 in an amount of about 7 wt %, and SDS in an amount of about 6 wt %.

(49) According to an exemplary embodiment, the concentrated liquids may include: sodium chloride, sodium monohydrogen phosphate, polysorbate 20, and sodium dodecyl sulfate (SDS). Particularly, the composition may include: NaCl in an amount of about 12.8 wt %, NaH.sub.2PO.sub.4 in an amount of about 2.8 wt %, polysorbate 20 in an amount of 10 volume % and SDS in an amount of about 4.8 wt %.

(50) In certain embodiments, other additives may be included in the composition to improve physical or chemical property of the composition, such as shelf-storage stability or solubility.

(51) In certain exemplary embodiments, the composition may be a solid powder which can be mixed and dissolved with a sample in water or aqueous solution.

(52) In other aspect, the composition and components thereof may be a powder or crystalline powder.

(53) Method of Extracting Mycotoxins

(54) The present invention provides methods of extracting and detecting mycotoxins from a sample. Particularly, methods of the invention include the use of the composition above and exclude the use of any organic solvent.

(55) In one embodiment, the method of extracting may comprise steps of: preparing a sample by combining the sample with a composition of the invention; and extracting mycotoxins from the prepared sample.

(56) In certain embodiments, the composition used in the method may include one or more of surfactants, one or more of polymers, one or more of viscosity modifiers, one or more of buffering salts. In an exemplary embodiment, the composition may include: PEG in an amount of about 40 wt %, sucrose in an amount of about 40 wt %, NaCl in an amount of about 7 wt %, NaH.sub.2PO.sub.4 in an amount of about 7 wt %, and SDS in an amount of about 6 wt %.

(57) In another embodiment, the method of extracting may comprise steps of: preparing a sample by combining the sample with a first and second concentrated liquid of the invention and water; and extracting mycotoxins from the prepared sample.

(58) In certain embodiments, the first and second concentrated liquids used in the method may include one or more of surfactants, one or more of buffering salts. In an exemplary embodiment, the composition may include: NaCl in an amount of about 12.4 wt %, NaH.sub.2PO.sub.4 in an amount of about 2.8 wt %, Polysorbate 20 in an amount of 10 volume %, and SDS in an amount of about 10 volume %.

(59) In the certain embodiments, the sample may be solid. In preparing the sample, the solid sample may be combined with the composition of the invention and water. In other certain embodiments, the sample may be liquid and the sample may be prepared by combining with the composition. In yet other embodiments, the prepared sample may be diluted to obtain detectable range of analytes included in the sample.

(60) In certain embodiments, preparation of the sample may be performed at a temperature of about 10 to 30? C., or room temperature, at which temperature the composition and the analytes, i.e. mycotoxins, may not be altered or deteriorate.

(61) In certain embodiments, the analytes in the sample may be extracted by any methods in the art. The method may include, but is not limited to, shaking, vortexing, ultrasonication, heat reflux, microwave-assisted extraction, controlled pressure drop extraction, and the like. In an exemplary embodiment, the analytes in the sample may be extracted by vortexing after combining the sample with the composition. Exemplary vortexing may be performed at least about 2 min.

(62) In certain embodiments, the method may further comprise filtering the prepared sample. In certain exemplary embodiments, any general method of filtering in the art may be used in the method of the invention. In certain exemplary embodiments, the filtering may be, but is not limited to, vacuum filtering, gravity filtering and the like. The filtering may also be performed with, but not limited to, filter paper, membrane, or adsorbent.

(63) In yet certain embodiments, the method may further comprise analyzing the mycotoxins from the sample. In certain exemplary embodiments, the analyzing may be performed after sample preparation using affinity chromatography. The analysis may use, but is not limited to, analytical chromatography columns such as liquid chromatography, high performance liquid chromatography (HPLC), reverse phase liquid chromatography, test strip, and the like. In particular, affinity chromatography columns or test strips may comprise affinity resin or species such as antibody, ligands, or chemical species having specificity toward mycotoxins.

(64) In an exemplary embodiment, a test strip comprising antibodies specific to aflatoxins may be used for detecting and analyzing aflatoxins in the prepared samples. It is appreciated that Afla-V? strip test (VICAM, Milford, MA) provides a range of options for method development in the invention.

(65) In certain embodiments, the method may further comprise quantitating a level of the mycotoxins in the sample. The mycotoxins may be detected by the test strip and test strip reader or by the affinity chromatography columns whereby the column eluate may be analyzed by, but not limited to, use of a fluorometer. It is appreciated that VICAM Series 4 EX fluorometer (VICAM, Milford, MA) provides a range of options for method development in the invention.

(66) In an exemplary embodiment, the level of mycotoxins may be quantitated by measuring the fluorescence of chemical species at a wavelength of about 454 nm in a single-cell fluorometer.

(67) In other embodiments, the methods may further include calibrating the detected level of the mycotoxins.

Example 1

(68) Materials and Reagent

(69) Materials and reagents (e.g. PEG 20,000, Sucrose, NaCl, Na.sub.2HPO.sub.4, SDS) were purchased commercially from Sigma Aldrich Co., St. Louis, MO or JT Baker/Avantor Performance Materials, Inc., Center Valley, PA

(70) Composition

(71) A composition is prepared by combining PEG 20,000 in an amount of about 40 wt %, sucrose in an amount of about 40 wt %, sodium chloride (NaCl) in an amount of about 7 wt %, sodium dihydrogen phosphate (Na.sub.2HPO.sub.4) in an amount of about 7 wt %, and SDS in an amount of about 6 wt %.

(72) Extraction and Assay

(73) Fine milled corn reference samples from Trilogy Laboratories for which aflatoxin levels were determined by HPLC were tested. The corn sample (5 g) was combined with 2 g of the composition and 25 mL of distilled water. The mixture was vortexed for about 2 minutes and filtered using a filter paper to remove solid debris from the sample. The liquid filtrate was obtained as an extract for analysis.

(74) The extract of about 100 ?L in volume was applied to an AFLA-V? strip and the strip was developed for about 5 min. Level of aflatoxin was determined using the Vertu strip test reader (VICAM, Milford, MA). The samples were run in triplicate.

(75) Result

(76) Each level of aflatoxin concentration was measured in three replicates. Individual data points, means and % coefficient of variability are presented in the table below.

(77) TABLE-US-00001 % CV Mean Standard (coefficient of HPLC Sample ppb (ppb) Deviation variability) detection 1 1.3 0.4 0.7 173 0 ppb QC corn 0.0 0.0 2 5.3 5.6 0.4 6 5.4 ppb AC287 5.6 6.0 3 8.3 8.2 0.6 8 8.4 ppb MTC9991 8.8 7.5 4 14.9 15.2 0.3 2 17.4 ppb MTC9993 15.3 15.5 5 21.4 21.7 0.5 2 21.2 ppb AC241 21.5 22.3 6 65.8 76.0 11.4 15 99.9 ppb AC279 74.0 88.3

(78) The above results show acceptable precision and accuracy at 5 ppb, 10 ppb, and 20 ppb in comparison with GIPSA requirements. Thus, the present invention provides a convenient and accurate extraction and detection methods of aflatoxins in a range of about 0 to 100 ppb.

Example 2

(79) Materials and Reagent

(80) Materials and reagents (e.g. PROCLIN 300 (TM, Supelco), Tween 20, Sucrose, NaCl, Na.sub.2HPO.sub.4, SDS) were purchased commercially from Sigma Aldrich Co St. Louis, MO

(81) First Concentrated Solution

(82) A first concentrated solution was prepared by combining 900 ml purified water, 48 grams of SDS, and 5 mL; of ProClin300 in a 1 L vessel. The mixture was stirred until all chemicals were dissolved in the solution. The final volume was brought to 1 L by addition of more purified water.

(83) Second Concentrated Solution

(84) A second concentrated solution was prepared by combining 800 mL of purified water, 124 grams of NaCl, 28 grams of Na.sub.2HPO.sub.4, 100 mL of Tween20 and 5 mL of ProClin300 in a 1 L vessel. The mixture was stirred until all chemicals were dissolved in the solution. The final volume was brought to 1 L by addition of more purified water.

(85) Extraction and Assay

(86) Three Peanut Paste samples from Trilogy Laboratories for which aflatoxin levels were determined by HPLC were tested. [A-PP-5 having 5 ppb peanut; A-PP-10 having 10 ppb peanut; and A-PP-21 having 21 ppb peanut]. In each case, the peanut sample (5 g) was first combined with 15 mL of distilled water. Then 5 mL of the first concentrated solution, and 5 mL of the second concentrated solution were added to the mixture. The mixture was vortexed for about 2 minutes and filtered using a filter paper to remove solid debris from the sample. The liquid filtrate was obtained as an extract for analysis.

(87) The extract of about 100 ?L in volume was applied to an AFLA-V? strip and the strip was developed for about 5 min. Level of aflatoxin was determined using the Vertu strip test reader (VICAM, Milford, MA). The samples were run in triplicate.

(88) Materials and Reagent

(89) Materials and reagents (e.g. PROCLIN 300 (TM, Supelco), Tween 20, NaCl, Na.sub.2HPO.sub.4, SDS) were purchased commercially from Sigma Aldrich Co St. Louis, MO

(90) First Concentrated Solution

(91) A first concentrated solution was prepared by combining 900 ml purified water, 48 grams of SDS, and 5 m; of ProClin300 in a 1 L vessel. The mixture was stirred until all chemicals were dissolved in the solution. The final volume was brought to 1 L by addition of more purified water.

(92) Second Concentrated Solution

(93) A second concentrated solution was prepared by combining 800 mL of purified water, 124 grams of NaCl, 28 grams of Na.sub.2HPO.sub.4, 100 mL of Tween20 and 5 mL of ProClin300 in a 1 L vessel. The mixture was stirred until all chemicals were dissolved in the solution. The final volume was brought to 1 L by addition of more purified water.

(94) Extraction and Assay

(95) Three peanut paste samples from Trilogy Laboratories for which aflatoxin levels were determined by HPLC were tested. [C-PP-5 having 5 ppb paste; C-PP-10 having 10 ppb paste; and C-PP-20 having 20 ppb paste; In each case, the peanut sample (5 g) was first combined with 15 mL of distilled water. Then 5 mL of the first concentrated solution, and 5 mL of the second concentrated solution were added to the mixture. The mixture was vortexed for about 2 minutes and filtered using a filter paper to remove solid debris from the sample.

(96) The filtered extract of about 100 ?L in volume was applied to an AFLA-V? strip and the strip was developed for about 5 min. Level of aflatoxin was determined using the Vertu strip test reader (VICAM, Milford, MA). The samples were run in triplicate.

(97) Result

(98) Each level of aflatoxin concentration was measured in three replicates. Individual data points, means and % coefficient of variability are presented in the table below.

(99) TABLE-US-00002 HPLC Mean Sample (ppb) T/C ppb (ppb) SD % CV A-PP-5 5 9.47 6.7 5 0.26 23 13.98 4.1 12.54 4.8 A-PP-10 10 6.34 9.8 10 0.04 1 6.33 9.8 6.83 9.2 C-PP-20 20 2.27 20.0 22 0.98 10 2.15 22.9 2.43 20.9

(100) The above results show acceptable precision and accuracy at 5 ppb, 10 ppb, 20 ppb, in comparison with GIPSA requirements. Thus, the present invention provides a convenient and accurate extraction and detection methods of aflatoxins.

(101) Materials and Reagent

(102) Materials and reagents (e.g. PROCLIN 300 (TM, Supelco), Tween 20, Sucrose, NaCl, Na.sub.2HPO.sub.4, SDS) were purchased commercially from Sigma Aldrich Co St. Louis, MO

(103) First Concentrated Solution

(104) A first concentrated solution was prepared by combining 900 ml purified water, 48 grams of SDS, and 5 m; of ProClin300 in a 1 L vessel. The mixture was stirred until all chemicals were dissolved in the solution. The final volume was brought to 1 L by addition of more purified water.

(105) Second Concentrated Solution

(106) A second concentrated solution was prepared by combining 800 mL of purified water, 124 grams of NaCl, 28 grams of Na.sub.2HPO.sub.4, 100 mL of Tween20 and 5 mL of ProClin300 in a 1 L vessel. The mixture was stirred until all chemicals were dissolved in the solution. The final volume was brought to 1 L by addition of more purified water.

(107) Extraction and Assay

(108) Five finely milled corn samples from Trilogy Laboratories for which aflatoxin levels were determined by HPLC were tested. In each case, the corn sample (5 g) was first combined with 15 mL of distilled water. Then 5 mL of the first concentrated solution, and 5 mL of the second concentrated solution were added to the mixture. The mixture was vortexed for about 2 minutes and filtered using a filter paper to remove solid debris from the sample. The liquid filtrate was obtained and diluted 1:1 with Afla-V diluents as an extract for analysis.

(109) The diluted extract of about 100 ?L in volume was applied to an AFLA-V? strip and the strip was developed for about 5 min. Level of aflatoxin was determined using the Vertu strip test reader (VICAM, Milford, MA). The samples were run in triplicate.

(110) Result

(111) Each level of aflatoxin concentration was measured in three replicates. Individual data points, means and % coefficient of variability are presented in the table below.

(112) TABLE-US-00003 Mean HPLC ID T/C ppb (ppb) (ppb) C1 19.43 2.1 1.6 <1 24.30 0.1 17.95 2.6 C2 8.56 7.4 7.0 5.4 9.61 6.6 9.06 7.0 C3 5.02 12.0 11.8 11 5.11 11.8 5.24 11.5 C4 2.45 20.8 21.4 21.2 2.36 21.4 2.26 22.0 C5 0.53 62.0 52.3 50.8 0.78 47.0 0.76 47.9

(113) Throughout this application, various publications, including United States patents, are referenced by author and year and patents by number. The disclosures of these publications and patents in their entireties are hereby incorporated by reference into this application.

(114) The present inventions have been described in detail including preferred embodiments thereof. However, it should be appreciated that those skilled in the art, upon consideration of the present disclosure, may make modifications and improvements within the spirit and scope of the present inventions.